Oxidative Stress-Related Susceptibility to Aneurysm in Marfan's Syndrome
Overview
Affiliations
The involvement of highly reactive oxygen-derived free radicals (ROS) in the genesis and progression of various cardiovascular diseases, including arrhythmias, aortic dilatation, aortic dissection, left ventricular hypertrophy, coronary arterial disease and congestive heart failure, is well-established. It has also been suggested that ROS may play a role in aortic aneurysm formation in patients with Marfan's syndrome (MFS). This syndrome is a multisystem disorder with manifestations including cardiovascular, skeletal, pulmonary and ocular systems, however, aortic aneurysm and dissection are still the most life-threatening manifestations of MFS. In this review, we will concentrate on the impact of oxidative stress on aneurysm formation in patients with MFS as well as on possible beneficial effects of some agents with antioxidant properties. Mechanisms responsible for oxidative stress in the MFS model involve a decreased expression of superoxide dismutase (SOD) as well as enhanced expression of NAD(P)H oxidase, inducible nitric oxide synthase (iNOS) and xanthine oxidase. The results of studies have indicated that reactive oxygen species may be involved in smooth muscle cell phenotype switching and apoptosis as well as matrix metalloproteinase activation, resulting in extracellular matrix (ECM) remodeling. The progression of the thoracic aortic aneurysm was suggested to be associated with markedly impaired aortic contractile function and decreased nitric oxide-mediated endothelial-dependent relaxation.
Curry-Koski T, Gusek B, Potter R, Jones T, Dickman R, Johnson N Int J Mol Sci. 2024; 25(23).
PMID: 39684412 PMC: 11641669. DOI: 10.3390/ijms252312702.
The role of oxidative stress in aortic dissection: a potential therapeutic target.
Xu S, Han X, Wang X, Yu Y, Qu C, Liu X Front Cardiovasc Med. 2024; 11:1410477.
PMID: 39070552 PMC: 11272543. DOI: 10.3389/fcvm.2024.1410477.
The Antioxidant Vitamin B12 Analogue Cobinamide as a Treatment for Marfan Syndrome.
Wagner A JACC Basic Transl Sci. 2024; 9(1):63-64.
PMID: 38362344 PMC: 10864960. DOI: 10.1016/j.jacbts.2023.09.011.
Hyperuricaemia Does Not Interfere with Aortopathy in a Murine Model of Marfan Syndrome.
Rodriguez-Rovira I, Lopez-Sainz A, Palomo-Buitrago M, Perez B, Jimenez-Altayo F, Campuzano V Int J Mol Sci. 2023; 24(14).
PMID: 37511051 PMC: 10379183. DOI: 10.3390/ijms241411293.
Pincemail J, Tchana-Sato V, Courtois A, Musumeci L, Cheramy-Bien J, Munten J Antioxidants (Basel). 2023; 12(5).
PMID: 37237972 PMC: 10215099. DOI: 10.3390/antiox12051106.